Back

Drugs targeting cardiac metabolism.

27 May 2019 (16:30 - 16:42)
Organised by:
Congress Presentation Part of: Emerging therapies in heart failure Pathophysiology HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Giuseppe Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Apelin pathway.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
Omecaptiv.
Professor J. Cleland (Glasgow, GB)
Slides Video
Presentation thumbnail
Vericiguat.
Professor B. Pieske (Rostock, DE)
Video
Presentation thumbnail
Nitroxyl donors.
Professor V. Mitrovic (Nauheim, DE)
Slides Video
Presentation thumbnail
B3 agonists.
Slides Video

Access the full session

Session thumbnail
Emerging therapies in heart failure

The Event

Event poster

Heart Failure 2019

27 May 2019 16:30 CET
You may be interested in
thumbnail
Congress Session
Metabolism and cardiovascular diseases: completely inseparable
28 August 2023
thumbnail
Congress Presentation
Statin users have lower fatty acid oxidative metabolisms in muscle mitochondria and have a higher content of long-chain and medium-chain acylcarnitines in muscles.
29 August 2025
thumbnail
Congress Presentation
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources